Shuttle Pharmaceuticals Holdings (SHPH) Long-Term Deferred Tax (2022 - 2025)

Shuttle Pharmaceuticals Holdings' Long-Term Deferred Tax history runs 4 years deep, the most recent figure standing at $12122.0 for Q4 2025.

• On a quarterly basis, Long-Term Deferred Tax fell 99.76% year-over-year to $12122.0 in Q4 2025; TTM through Dec 2025 was $12122.0, a 99.76% decrease from a year earlier, with the FY2025 full-year figure at $12122.0, down 99.76% from the prior year.
• Long-Term Deferred Tax eased to $12122.0 in Q4 2025 per SHPH's latest filing, from $30305.0 in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $5.1 million in Q4 2024 and bottomed at $12122.0 in Q4 2025.
• The 4-year median for Long-Term Deferred Tax is $71880.0 (2025), against an average of $1.4 million.
• Across the five-year window, Long-Term Deferred Tax soared 144.7% in 2023 and sank 99.76% in 2025, its largest moves.
• Year by year, Long-Term Deferred Tax stood at $1.4 million in 2022, then surged by 144.7% to $3.4 million in 2023, then surged by 47.95% to $5.1 million in 2024, then sank by 99.76% to $12122.0 in 2025.
• Per Business Quant, the three latest SHPH Long-Term Deferred Tax figures stand at $12122.0 (Q4 2025), $30305.0 (Q3 2025), and $48487.0 (Q2 2025).